Atlas Trials

Memantine Augmentation of Targeted Cognitive Training in Schizophrenia

Clinical trial NCT04857983 · COMPLETED

Trial details

NCT number
NCT04857983
Sponsor
University of California, San Diego
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
SchizophreniaSchizoaffective Disorder
Start date
2021-07-06
Primary completion
2025-03-30
Enrollment
62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.